Major Market Shift in Needle-Free Drug Delivery Devices Industry: Advancements In Dual Chamber Inhalers Revolutionize The Needle-Free Drug Delivery Market

What Is the Forecasted Market Size and Growth Rate for the Needle-Free Drug Delivery Devices Market?
The market for needle-free drug delivery devices has seen swift expansion in the past few years. The projections reveal growth from $16.7 billion in 2024 to $18.67 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. This growth during the historic timeline can be credited to the escalating incidence of chronic ailments, the rising preference for painless drug administration techniques, the sizable aged population, prioritization of patient safety and adherence, regulatory endorsement for needle-free technologies, and the expansion of the pharmaceutical sector.

The market for needle-free drug delivery devices is predicted to experience swift expansion in the following years, reaching $28.86 billion in 2029 with a compound annual growth rate (CAGR) of 11.5%. The growth expected within this period can be linked to the rising demand for pain-free drug administration, increasing focus on patient-centered healthcare services, widening use in children and the elderly, increasing cases of chronic diseases that require regular injections, advancements in technology that improve the efficiency and use of these devices, broader access to healthcare in emerging economies, and the surge in research and development investment for new delivery systems. The forecast period will likely witness a rise in the use of wearable and interconnected devices, the advent of innovative microfluidic technologies, an increasing focus on kid-friendly needle-free solutions, the incorporation of artificial intelligence and machine learning algorithms, and more application in home healthcare settings.

What Are the Key Drivers Behind the Growth of the Needle-Free Drug Delivery Devices Market?
The escalating incidence of diabetes is anticipated to spur the advancement of the needle-free drug delivery device market. This persistent medical problem, characterized by high levels of glucose in the blood, originates from insufficient insulin production or the body's poor processing of insulin. The ever-increasing occurrence of diabetes is attributed to inactive lifestyles, improper eating regimens, genetic susceptibility, urbanization, and a growing elderly population. This issue is further exacerbated by inadequate healthcare accessibility and escalating obesity figures worldwide. Needle-less drug delivery devices serve as a solution to traditional insulin injection methods in diabetes management. These devices leverage technologies like jet injectors or transdermal patches to administer insulin through the skin, eliminating the use of needles. This results in reduced discomfort and fear associated with injections, improving overall comfort levels. For example, the National Health Service, a UK governmental body, stated in June 2024 that the NHS had identified over half a million (549,000) additional individuals in England who could potentially develop type 2 diabetes in 2023. This elevated the total number of people diagnosed with non-diabetic hyperglycemia or pre-diabetes, registered with a GP, to 3,615,330. This presents a significant rise compared to the 3,065,825 cases in 2022, marking an almost 20% surge. Hence, the increasing prevalence of diabetes is catalyzing the progression of the needle-free drug delivery device market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

Which Businesses Are at the Forefront of Needle-Free Drug Delivery Devices Market Development?
Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG

What Are the Latest Innovations in the Needle-Free Drug Delivery Devices Market?
Key industry players in the needle-free drug delivery device market are concentrating on innovative approaches like dual chamber inhalers to boost efficiency and ease of application and to fulfill evolving requirements of patients and healthcare providers. The dual-chamber inhaler is a two-compartment tool that carries distinct medications separately. This configuration permits several drugs to be combined in a single inhaler, simplifying the treatment process and enhancing convenience for the patients. For example, in April 2024, Berry Global, the American plastic manufacturing corporation, introduced BerryHaler, an innovative dry powder inhaler (DPI) envisaged to transform patient-centric healthcare solutions. The dual-chamber inhaler features a dose counter ensuring accurate medication delivery. Its wholly plastic composition devoid of metal parts makes it ideal for complex inhalation treatments and it simplifies drug dosing and combines multiple drugs effectively. Advanced characteristics include a bi-directional mouthpiece cover for comfort and cleanliness, as well as audible cues to signal correct usage. The integrated dose counter helps track exact medication usage, avoiding dosage mistakes.

How Is the Needle-Free Drug Delivery Devices Market Segmented?
The needle-free drug delivery devices market covered in this report is segmented -

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types
2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications
3) By End-User: Hospitals And Clinics, Home Healthcare

Subsegments:
1) By Inhalers: Dry Powder Inhalers (Dpi), Metered Dose Inhalers (Mdi), Nebulizers
2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors
3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays
4) By Transdermal Patches: Microneedle Patches, Conventional Patches ( Nicotine, Hormonal, Pain Relief)
5) By Other Device Types: Oral Drug Delivery Devices, Implantable Drug Delivery Systems, Sublingual Drug Delivery Devices

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

Where Is the Needle-Free Drug Delivery Devices Market Growth Most Prominent?
North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Needle-Free Drug Delivery Devices Global Market Report?

- Market Size Analysis: Analyze the Needle-Free Drug Delivery Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Needle-Free Drug Delivery Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Needle-Free Drug Delivery Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Needle-Free Drug Delivery Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15615

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.